O'Reilly RJ - Search Results

1

T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.

Papadopoulos EB, Carabasi MH, Castro-Malaspina H, Childs BH, Mackinnon S, Boulad F, Gillio AP, Kernan NA, Small TN, Szabolcs P, Taylor J, Yahalom J, Collins NH, Bleau SA, Black PM, Heller G, O'Reilly RJ, Young JW. Papadopoulos EB, et al. Blood. 1998 Feb 1;91(3):1083-90. Blood. 1998. PMID: 9446672 Free article.

2

Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation.

Offit K, Burns JP, Cunningham I, Jhanwar SC, Black P, Kernan NA, O'Reilly RJ, Chaganti RS. Offit K, et al. Blood. 1990 Mar 15;75(6):1346-55. Blood. 1990. PMID: 2310831 Free article.

3

Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms.

Bordignon C, Keever CA, Small TN, Flomenberg N, Dupont B, O'Reilly RJ, Kernan NA. Bordignon C, et al. Blood. 1989 Nov 1;74(6):2237-43. Blood. 1989. PMID: 2529927 Free article.

4

Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.

Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, Pecora A, Gillio A, Kernan NA, O'Reilly RJ. Keever CA, et al. Blood. 1989 Apr;73(5):1340-50. Blood. 1989. PMID: 2649174 Free article.

5

Host origin of the human hematopoietic microenvironment following allogeneic bone marrow transplantation.

Laver J, Jhanwar SC, O'Reilly RJ, Castro-Malaspina H. Laver J, et al. Blood. 1987 Dec;70(6):1966-8. Blood. 1987. PMID: 3315046 Free article.

6

Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.

Kernan NA, Collins NH, Juliano L, Cartagena T, Dupont B, O'Reilly RJ. Kernan NA, et al. Blood. 1986 Sep;68(3):770-3. Blood. 1986. PMID: 3527302 Free article.

7

Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?

Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, O'Reilly RJ. Mackinnon S, et al. Bone Marrow Transplant. 1995 Apr;15(4):591-4. Bone Marrow Transplant. 1995. PMID: 7655386

8

Umbilical cord blood infusion in a patient for correction of Wiskott-Aldrich syndrome.

Kernan NA, Schroeder ML, Ciavarella D, Preti RA, Rubinstein P, O'Reilly RJ. Kernan NA, et al. Blood Cells. 1994;20(2-3):245-8. Blood Cells. 1994. PMID: 7749101

9

Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia.

Mackinnon S, Barnett L, Heller G, O'Reilly RJ. Mackinnon S, et al. Blood. 1994 Jun 1;83(11):3409-16. Blood. 1994. PMID: 8193379 Free article.

10

The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.

Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ. Lucas KG, et al. Blood. 1996 Mar 15;87(6):2594-603. Blood. 1996. PMID: 8630428 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters